Inferensys

Services

Bio-AI and Generative Biology Solutions

Application of multimodal models and graph neural networks to accelerate drug discovery, protein structure prediction, enzyme design, and automated生物系统设计 at digital speed. Sub-services include AI for small molecule drug discovery, CRISPR-GPT integration services, generative AI for enzyme engineering, and computational biology foundation model development.
ML engineer developing custom LLM, model architecture diagrams on screens, technical deep work environment.
Services

Bio-AI and Generative Biology Solutions

Application of multimodal models and graph neural networks to accelerate drug discovery, protein structure prediction, enzyme design, and automated生物系统设计 at digital speed. Sub-services include AI for small molecule drug discovery, CRISPR-GPT integration services, generative AI for enzyme engineering, and computational biology foundation model development.

Generative Protein Design Engineering

Development of AI systems that generate novel, stable, and functional protein sequences for therapeutic, industrial, and diagnostic applications, moving beyond prediction to de novo creation.

AI-Driven Drug Discovery Platform Development

Architecture of end-to-end computational platforms that integrate generative AI, molecular simulation, and high-throughput screening data to accelerate small molecule and biologic lead identification.

CRISPR-AI Integration and Screening Services

Engineering of AI platforms that design optimal CRISPR guides, predict off-target effects, and analyze high-content screening data to massively accelerate functional genomics and therapeutic development.

Bio-AI Foundation Model Consulting

Strategic guidance and technical implementation for training or fine-tuning large-scale, multimodal foundation models (e.g., ESM, AlphaFold) on proprietary biological data for competitive advantage.

Computational Biology Model Fine-tuning

Specialized adaptation of pre-trained biological AI models (for structure, function, interaction) to specific organism, disease, or experimental data contexts to achieve lab-validated accuracy.

Bio-AI Data Pipeline and MLOps Engineering

Construction of robust, scalable data ingestion, featurization, and model deployment pipelines for heterogeneous biological data types (omics, imaging, text) ensuring reproducibility and compliance.

AI for Biomolecular Structure Prediction Services

Implementation and customization of state-of-the-art deep learning systems (like AlphaFold, RoseTTAFold) for predicting protein, RNA, and complex structures with atomic-level accuracy for R&D.

Generative AI for Enzyme Engineering

Design of AI workflows that generate and optimize enzyme variants for improved catalytic activity, substrate specificity, and stability in industrial bioprocesses and green chemistry.

AI-Powered Lab Automation Systems Integration

Integration of machine learning with robotic liquid handlers, high-content screeners, and other lab hardware to create closed-loop, autonomous experimentation systems that design, run, and analyze experiments.

Synthetic Biological Data Generation Services

Creation of high-fidelity, privacy-preserving synthetic datasets for genomics, proteomics, and clinical trials to overcome data scarcity, accelerate model training, and ensure regulatory compliance.

Bio-AI for Precision Medicine Development

Development of AI systems that integrate multi-omic patient data (genomic, transcriptomic, proteomic) with clinical records to identify biomarkers, predict treatment response, and enable personalized therapeutic strategies.

AI-Driven Clinical Trial Optimization Services

Application of machine learning to optimize patient recruitment, site selection, and trial design, using predictive analytics to reduce costs, timelines, and attrition rates in pharmaceutical development.

Graph Neural Network Solutions for Biological Networks

Engineering of GNN-based AI to model complex biological interactions (protein-protein, gene regulatory, metabolic pathways) for drug target identification, polypharmacology, and systems biology insights.

Multimodal Bio-Data Fusion AI Integration

Development of AI systems that jointly analyze and interpret disparate biological data modalities (text literature, imaging, sequencing, sensors) to uncover novel, holistic insights for research and development.

Bio-AI Regulatory Compliance and Validation

Services to ensure AI/ML models used in drug discovery, diagnostics, and clinical decision support are developed, validated, and documented to meet FDA, EMA, and ISO 13485 regulatory standards for market approval.